Ophthalmology biotechnology company.
EyeBiotech has raised €118M across 2 funding rounds from 7 investors, most recently a Series A round in Nov 2023. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-11-14 | Series A | €61M | Bain Capital Life Sciences,Jeito Capital,MRL Ventures Fund,Omega Funds,Samsara Biocapital,SV Health Investors+1 more | View deal → |
| 2022-02-22 | Series A | €57M | Jeito Capital,MRL Ventures Fund,Samsara Biocapital,SV Health Investors | View deal → |
